1/5/2017 – Cancer diagnostic startup co-founded by Macro alum Seungpyo Hong raises $2.9M

Capio Biosciences aims to commercialize a device that could help cancer researchers capture greater numbers of circulating tumor cells (CTCs), which are a valuable indicator of how a cancer (and treatment) is progressing. Dr. Hong recently joined the faculty at the University of Wisconsin-Madison, having previously been at the University of Illinois at Chicago. Read More